LBI-HTA - Publications - Search - Person: McGahan, L.
Number of items: 3.

McGahan, L. (2016): Atezolizumab (Tecentriq™) for the treatment of locally advanced and metastatic urothelial carcinoma. DSD: Horizon Scanning in Oncology 61.

McGahan, L. (2017): Palbociclib (Ibrance®) in combination with fulvestrant for the treatment of hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer. DSD: Horizon Scanning in Oncology 64.

McGahan, L. (2017): Atezolizumab (Tecentriq®) in previously treated non-small cell lung cancer (NSCLC). DSD: Horizon Scanning in Oncology 68.

This list was generated on Fri May 26 00:01:29 2017 CEST.